---
figid: PMC4055378__BMRI2014-368681.001
figtitle: Methotrexate action mechanism
organisms:
- Homo sapiens
- Nicotiana tabacum
organisms_ner:
- Homo sapiens
- Drosophila melanogaster
pmcid: PMC4055378
filename: BMRI2014-368681.001.jpg
figlink: /pmc/articles/PMC4055378/figure/fig1/
number: F1
caption: 'Methotrexate action mechanism. Left panel represents the intervention of
  MTX in de novo pyrimidine synthesis, folate, and methionine pathways by the inhibition
  of key enzymes. Right panel shows the effect of MTX in de novo purine synthesis
  and adenosine pathway by ATIC inhibition. 5-MTHF: 5-methyltetrahydrofolate; 5,10-MTHF:
  5,10-methylenetetrahydrofolate; ABC: ATP-binding cassette; ADORA: adenosine receptor;
  AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide; AMP: adenosine monophosphate;
  ATIC: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase; ATP: adenosine
  triphosphate; DHF: dihydrofolate; dTMP: deoxythymidine monophosphate; dUMP: deoxyuridine
  monophosphate; FAICAR: 5-formamidoimidazole-4-carboxamide ribonucleotide; IMP: inosine
  monophosphate; MTHFR: methylenetetrahydrofolate reductase; MTX: methotrexate; MTXPG:
  methotrexate polyglutamate; SLC: solute carrier; THF: tetrahydrofolate.'
papertitle: 'Prediction of Methotrexate Clinical Response in Portuguese Rheumatoid
  Arthritis Patients: Implication of MTHFR rs1801133 and ATIC rs4673993 Polymorphisms.'
reftext: Aurea Lima, et al. Biomed Res Int. 2014;2014:368681.
year: '2014'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9219219
figid_alias: PMC4055378__F1
figtype: Figure
redirect_from: /figures/PMC4055378__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC4055378__BMRI2014-368681.001.html
  '@type': Dataset
  description: 'Methotrexate action mechanism. Left panel represents the intervention
    of MTX in de novo pyrimidine synthesis, folate, and methionine pathways by the
    inhibition of key enzymes. Right panel shows the effect of MTX in de novo purine
    synthesis and adenosine pathway by ATIC inhibition. 5-MTHF: 5-methyltetrahydrofolate;
    5,10-MTHF: 5,10-methylenetetrahydrofolate; ABC: ATP-binding cassette; ADORA: adenosine
    receptor; AICAR: 5-aminoimidazole-4-carboxamide ribonucleotide; AMP: adenosine
    monophosphate; ATIC: 5-aminoimidazole-4-carboxamide ribonucleotide formyltransferase;
    ATP: adenosine triphosphate; DHF: dihydrofolate; dTMP: deoxythymidine monophosphate;
    dUMP: deoxyuridine monophosphate; FAICAR: 5-formamidoimidazole-4-carboxamide ribonucleotide;
    IMP: inosine monophosphate; MTHFR: methylenetetrahydrofolate reductase; MTX: methotrexate;
    MTXPG: methotrexate polyglutamate; SLC: solute carrier; THF: tetrahydrofolate.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MTX1
  - CCL21
  - ATP8A2
  - ATIC
  - IMPA1
  - BRAP
  - APRT
  - MFAP1
  - MTHFR
  - ADORA1
  - ADORA2A
  - ADORA2B
  - ADORA3
  - ABCB6
  - slc
  - CkIIbeta
  - Andorra
  - Anp
  - Acam
  - de
  - ATPsynbeta
  - Atpalpha
  - Hf
  - CG11089
  - Imp
  - CG11110
  - CG17029
  - CG17028
  - CG17027
  - CG9391
  - CG9389
  - Amph
  - SRPK
  - Pyrimidine
  - pyrimidine
  - 5-MTHF
  - Adenosine
  - adenosine
  - folate
  - Inosine
  - Methionine
  - Purine
  - purine
---
